カテゴリ： visiongain, 世界, 医療/バイオ

アレルギー性鼻炎薬のグローバル市場2023-2033：抗ヒスタミン薬、免疫療法、コルチコステロイド、うっ血除去剤、その他

■ 英語タイトル：Allergic Rhinitis Drugs Market Report 2023-2033 : Forecasts by Treatment (Antihistamines, Immunotherapy (SCIT, SLIT), Corticosteroids, Decongestants, Others), by Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), by Route of Administration (Oral, Nasal, Intraocular, Intravenous), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

調査会社visiongain社が発行したリサーチレポート（データ管理コード：VGA23FB015）■ 発行会社/調査会社：visiongain
■ 商品コード：VGA23FB015
■ 発行日：2023年1月30日
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：269
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Sigle User（1名様閲覧用、1年間、印刷不可）GBP3,950 ⇒換算￥750,500見積依頼/購入/質問フォーム
Enterprise（法人閲覧用、1年間、印刷可）GBP6,950 ⇒換算￥1,320,500見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM（デジタル著作権管理）付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※visiongain社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アレルギー性鼻炎薬のグローバル市場2023-2033：抗ヒスタミン薬、免疫療法、コルチコステロイド、うっ血除去剤、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Visiongain社の本調査資料は、世界のアレルギー性鼻炎薬市場規模が2033年までにCAGR 3.78%で成長すると推測しています。本資料は、アレルギー性鼻炎薬の世界市場について幅広く調査を行い、レポート概要、エグゼクティブサマリー、市場動向、治療種類別（抗ヒスタミン薬、免疫療法、コルチコステロイド、うっ血除去剤、その他）分析、疾患種類別（季節性アレルギー性鼻炎、通年性アレルギー性鼻炎、職業性アレルギー性鼻炎）分析、投与経路別（経口、鼻、眼内、静脈内）分析、流通チャネル別（小売薬局、病院薬局、オンライン薬局）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、企業情報など、以下のようにまとめています。尚、Alcon、AstraZeneca、Bayer AG、Dr Reddy's Laboratories、GlaxoSmithKline PLC、Johnson & Johnson、Merck & Co、Sanofi S.A.、Sun Pharmaceuticals、Teva Pharmaceutical Industries Ltdなどの企業情報を含んでいます。
・レポート概要
・エグゼクティブサマリー
・市場動向
・世界のアレルギー性鼻炎薬市場規模：治療種類別
- 抗ヒスタミン薬の市場規模
- 免疫療法の市場規模
- コルチコステロイドの市場規模
- うっ血除去剤の市場規模
- その他治療の市場規模
・世界のアレルギー性鼻炎薬市場規模：疾患種類別
- 季節性アレルギー性鼻炎の市場規模
- 通年性アレルギー性鼻炎の市場規模
- 職業性アレルギー性鼻炎の市場規模
・世界のアレルギー性鼻炎薬市場規模：投与経路別
- 経口用アレルギー性鼻炎薬の市場規模
- 鼻用アレルギー性鼻炎薬の市場規模
- 眼内用アレルギー性鼻炎薬の市場規模
- 静脈内用アレルギー性鼻炎薬の市場規模
・世界のアレルギー性鼻炎薬市場規模：流通チャネル別
- 小売薬局チャネルの市場規模
- 病院薬局チャネルの市場規模
- オンライン薬局チャネルの市場規模
・世界のアレルギー性鼻炎薬市場規模：地域別
- 北米のアレルギー性鼻炎薬市場規模
- ヨーロッパのアレルギー性鼻炎薬市場規模
- アジア太平洋のアレルギー性鼻炎薬市場規模
- 中南米のアレルギー性鼻炎薬市場規模
- 中東・アフリカのアレルギー性鼻炎薬市場規模
・企業情報

The Allergic Rhinitis Drugs Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advent of Innovative Intranasal Therapies for Treatment of Allergic Rhinitis
Intranasal therapies are gaining acceptance owing to their better safety and efficacy. This route of administration is also recommended by physicians and allergists since they do not have any systemic side-effects and their adequate concentrations can be achieved at receptor sides in nasal mucosa. Their adverse effects are limited to dryness, sneezing and stinging of nasal mucosa. Several companies are developing innovative intranasal drugs owing to their inherent advantages over other routes of administration. For instance, ClorNasal™ developed by Dr. Ferrer BioPharma is recognized as the best intranasal pharmacological formulation in the world. It is used in the treatment of several ailments including allergic rhinitis, Respiratory Syncytial Virus (RSV) Infection and COVID-19. Similarly, Altamira Therapeutics Ltd. Developed the nasal spray Bentrino. It prevents the onset of allergic symptoms by airborne allergens such as dust mites, and pollens.

Similarity of Symptoms With Other Diseases
Allergic rhinitis is an infection caused due to allergic reaction of immune system to an allergen. Some of the most common symptoms of allergic rhinitis include stuffy nose, watery eyes, itchy mouth, sneezing, post-nasal drip, sore throat, facial pain or pressure, partial loss of hearing, smell, and taste, and fatigue among others. The symptoms are very similar to cold and cough which might be caused by virus and not by any of the agents that cause allergies. The allergies can also trigger other conditions such as asthma, sinusitis, otitis media or eczema if not treatment well in time. Selection of the right drug candidate remains a major problem in the absence of accurate diagnosis. Administration of immunotherapy or allergy shots may have serious side effects such as hives and rash. It may sometimes have dangerous side effects such as anaphylaxis which may require years of treatment.

Adverse Effects of Drugs Used in Allergic Rhinitis Treatment
Allergic medications are mostly used over a long period of time to keep the lifestyle unaffected by different types of allergens in the environment. Antihistamines are the most widely used drug type for treatment of allergic infections. Some of the short-term side-effects of antihistamines include constipation, urinary retention, dry mouth, enhanced appetite, and worsen narrow-angle glaucoma. Several side-effects of nasal decongestants include high blood pressure, irritability, headache, and sleeplessness. Topical corticosteroids cause absorption of the drug into the systemic circulation which has potential to cause disturbance to the normal hormonal levels in the body. Corticosteroid ocular solutions can cause glaucoma, cataract and other eye infections. Intranasal corticosteroids can irritate nasal mucosa and also affect the cell lining of mouth and throat make them dry and soar. Oral corticosteroids are associated with side-effects such as osteoporosis, stomach ulceration, hyperglycaemia, increased blood pressure and muscle weakness.

What Questions Should You Ask before Buying a Market Research Report?
• How is the Allergic Rhinitis Drugs Market evolving?
• What is driving and restraining the Allergic Rhinitis Drugs Market?
• How will each Allergic Rhinitis Drugs submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Allergic Rhinitis Drugs submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Allergic Rhinitis Drugs Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Allergic Rhinitis Drugs development projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Allergic Rhinitis Drugs development projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Allergic Rhinitis Drugs Market?
• Where is the Allergic Rhinitis Drugs Market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Allergic Rhinitis Drugs Market today, and over the next 10 years:
• Our 269-page report provides 105 tables and 173 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Allergic Rhinitis Drugs Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising prices of allergic rhinitis drugs and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Treatment Type
• Antihistamines
• Immunotherapy
– Subcutaneous Immunotherapy (SCIT)
– Sublingual Immunotherapy (SLIT)
• Corticosteroids
• Decongestants
• Others

Disease Type
• Seasonal Allergic Rhinitis
• Perennial Allergic Rhinitis
• Occupational Allergic Rhinitis

Route of Administration
• Oral
• Nasal
• Intraocular
• Intravenous

Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online channels

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Allergic Rhinitis Drugs Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Alcon
• AstraZeneca
• Bayer AG
• Dr Reddy’s Laboratories
• GlaxoSmithKline PLC
• Johnson & Johnson
• Merck & Co
• Sanofi S.A.
• Sun Pharmaceuticals
• Teva Pharmaceutical Industries Ltd

Overall world revenue for Allergic Rhinitis Drugs Market, 2023 to 2033 in terms of value the market will surpass US$12,410 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Allergic Rhinitis Drugs Market, 2023 to 2033 report help you?
In summary, our 260+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Allergic Rhinitis Drugs Market, 2023 to 2033 Market, with forecasts for Type of Treatment, Disease, Route of Administration and Distribution channel at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Allergic Rhinitis Drugs Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Allergic Rhinitis Drugs Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Allergic Rhinitis Drugs Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Allergic Rhinitis Drugs Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Awareness About Allergies and Available Treatment Options
3.2.1.2 Increasing Prevalence of Respiratory Disorders
3.2.1.3 Launch of Effective and Novel Drug Delivery Systems
3.2.2 Market Restraining Factors
3.2.2.1 Adverse Effects of Drugs Used in Treatment of Allergic Rhinitis
3.2.2.2 Similarity of Symptoms with Other Diseases
3.2.3 Market Opportunities
3.2.3.1 Increasing Advancements in Allergen Immunotherapy (AIT)
3.2.3.2 Favourable Government Initiatives to Promote Awareness Regarding Allergic Rhinitis
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Allergic Rhinitis Drugs Market Analysis by Treatment Type
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
4.4 Antihistamines
4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Immunotherapy
4.5.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.5.3 Sublingual immunotherapy (SLIT)
4.5.3.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.3.2 Market Share by Region, 2023 & 2033 (%)
4.5.4 Sublingual immunotherapy (SLIT)
4.5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.4.2 Market Share by Region, 2023 & 2033 (%)
4.6 Corticosteroids
4.6.1 Market Size by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Decongestants
4.7.1 Market Size by Region, 2023-2033 (US$ Mn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Others
4.8.1 Market Size by Region, 2023-2033 (US$ Mn)
4.8.2 Market Share by Region, 2023 & 2033 (%)

5 Allergic Rhinitis Drugs Market Analysis by Disease Type
5.1 Key Findings
5.2 Product Segment: Market Attractiveness Index
5.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease Type
5.4 Seasonal Allergic Rhinitis
5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Perennial Allergic Rhinitis
5.5.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Occupational Allergic Rhinitis
5.6.1 Market Size by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Allergic Rhinitis Drugs Market Analysis by Route of Administration
6.1 Key Findings
6.2 Product Segment: Market Attractiveness Index
6.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
6.4 Oral
6.4.1 Market Size by Region, 2023-2033 (US$ Mn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Nasal
6.5.1 Market Size by Region, 2023-2033 (US$ Mn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Intraocular
6.6.1 Market Size by Region, 2023-2033 (US$ Mn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Intravenous
6.7.1 Market Size by Region, 2023-2033 (US$ Mn)
6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Allergic Rhinitis Drugs Market Analysis by Distribution Channel
7.1 Key Findings
7.2 Product Segment: Market Attractiveness Index
7.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
7.4 Retail Pharmacies
7.4.1 Market Size by Region, 2023-2033 (US$ Mn)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Hospital Pharmacies
7.5.1 Market Size by Region, 2023-2033 (US$ Mn)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Online Pharmacies
7.6.1 Market Size by Region, 2023-2033 (US$ Mn)
7.6.2 Market Share by Region, 2023 & 2033 (%)

8 Allergic Rhinitis Drugs Market Analysis by Region
8.1 Key Findings
8.2 Regional Segment: Market Attractiveness Index
8.3 Allergic Rhinitis Drugs Market Size Estimation and Forecast

9 North America Allergic Rhinitis Drugs Market Analysis
9.1 Key Findings
9.2 North America Allergic Rhinitis Drugs Market Attractiveness Index
9.3 North America Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
9.5 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
9.6 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
9.7 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
9.8 North America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
9.9 U.S. Allergic Rhinitis Drugs Market Analysis
9.10 Canada Allergic Rhinitis Drugs Market Analysis

10 Europe Allergic Rhinitis Drugs Market Analysis
10.1 Key Findings
10.2 Europe Allergic Rhinitis Drugs Market Attractiveness Index
10.3 Europe Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
10.5 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
10.6 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
10.7 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
10.8 Europe Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
10.9 Germany Allergic Rhinitis Drugs Market Analysis
10.10 France Allergic Rhinitis Drugs Market Analysis
10.11 UK Allergic Rhinitis Drugs Market Analysis
10.12 Italy Allergic Rhinitis Drugs Market Analysis
10.13 Spain Allergic Rhinitis Drugs Market Analysis
10.14 Russia Allergic Rhinitis Drugs Market Analysis
10.15 Rest of Europe Allergic Rhinitis Drugs Market Analysis

11 Asia Pacific Allergic Rhinitis Drugs Market Analysis
11.1 Key Findings
11.2 Asia Pacific Allergic Rhinitis Drugs Market Attractiveness Index
11.3 Asia Pacific Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
11.5 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
11.6 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
11.7 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
11.8 Asia Pacific Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
11.9 Japan Allergic Rhinitis Drugs Market Analysis
11.10 China Allergic Rhinitis Drugs Market Analysis
11.11 India Allergic Rhinitis Drugs Market Analysis
11.12 Australia Allergic Rhinitis Drugs Market Analysis
11.13 South Korea Allergic Rhinitis Drugs Market Analysis
11.14 Rest of Asia Pacific Allergic Rhinitis Drugs Market Analysis

12 Latin America Allergic Rhinitis Drugs Market Analysis
12.1 Key Findings
12.2 Latin America Allergic Rhinitis Drugs Market Attractiveness Index
12.3 Latin America Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
12.5 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
12.6 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
12.7 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
12.8 Latin America Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
12.9 Brazil Allergic Rhinitis Drugs Market Analysis
12.10 Mexico Allergic Rhinitis Drugs Market Analysis
12.11 Rest of Latin America Allergic Rhinitis Drugs Market Analysis

13 MEA Allergic Rhinitis Drugs Market Analysis
13.1 Key Findings
13.2 MEA Allergic Rhinitis Drugs Market Attractiveness Index
13.3 MEA Allergic Rhinitis Drugs Market by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Country
13.5 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Treatment Type
13.6 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Disease type
13.7 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Route of Administration
13.8 MEA Allergic Rhinitis Drugs Market Size Estimation and Forecast by Distribution Channel
13.9 GCC Allergic Rhinitis Drugs Market Analysis
13.10 South Africa Allergic Rhinitis Drugs Market Analysis
13.11 Rest of MEA Allergic Rhinitis Drugs Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2021
14.2 ALCON AG
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2017-2021
14.2.3.2 R&D, 2017-2021
14.2.3.3 Regional Market Shares, 2021
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 AstraZeneca plc
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2021
14.3.3.2 R&D, 2017-2021
14.3.3.3 Regional Market Shares, 2021
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Bayer AG
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2021
14.4.3.2 R&D, 2017-2021
14.4.3.3 Regional Market Shares, 2021
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Dr Reddy’s Laboratories Ltd.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2021
14.5.3.2 R&D, 2017-2021
14.5.3.3 Regional Market Shares, 2021
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 GlaxoSmithKline plc
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2017-2021
14.6.3.2 R&D, 2017-2021
14.6.3.3 Regional Market Shares, 2021
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Johnson & Johnson
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2017-2021
14.7.3.2 R&D, 2017-2021
14.7.3.3 Regional Market Shares, 2021
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Merck & Co.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2021
14.8.3.2 R&D, 2017-2021
14.8.3.3 Regional Market Shares, 2021
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 Sanofi SA
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2017-2021
14.9.3.2 R&D, 2017-2021
14.9.3.3 Regional Market Shares, 2021
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Sun Pharmaceutical Industries Limited
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2017-2021
14.10.3.2 R&D, 2017-2021
14.10.3.3 Regional Market Shares, 2021
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Teva Pharmaceutical Industries Ltd.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2017-2021
14.11.3.2 R&D, 2017-2021
14.11.3.3 Regional Market Shares, 2021
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のそう痒症治療薬市場2023-2030：疾患種類別（アトピー性皮膚炎、アレルギー性接触皮膚炎、蕁麻疹）、製品別（コルチコステロイド、抗ヒスタミン薬）、地域別
  • 世界のそう痒症治療薬市場2023-2030：疾患種類別（アトピー性皮膚炎、アレルギー性接触皮膚炎、蕁麻疹）、製品別（コルチコステロイド、抗ヒスタミン薬）、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(VGA23FB015 )"アレルギー性鼻炎薬のグローバル市場2023-2033：抗ヒスタミン薬、免疫療法、コルチコステロイド、うっ血除去剤、その他" (英文：Allergic Rhinitis Drugs Market Report 2023-2033 : Forecasts by Treatment (Antihistamines, Immunotherapy (SCIT, SLIT), Corticosteroids, Decongestants, Others), by Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), by Route of Administration (Oral, Nasal, Intraocular, Intravenous), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis)はvisiongain社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。